A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT04839328 · COMPLETED
Trial details
- NCT number
- NCT04839328
- Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-20
- Primary completion
- 2022-10-25
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.